Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chozmit is a branded dietary supplement marketed by Vanprom Lifesciences. It is formulated as a soft gelatin capsule containing a combination of active ingredients, including coenzyme Q10 (ubidecarenone), omega-3 fatty acids (eicosapentaenoic acid and docosahexaenoic acid), ginkgo biloba, lycopene, and selenium dioxide. The supplement is designed to support cardiovascular health, enhance cellular energy production, provide antioxidant protection against oxidative stress, and support cognitive function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chozmit.